These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12715326)

  • 41. Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection.
    Ogawa E; Otaguro S; Murata M; Kainuma M; Sawayama Y; Furusyo N; Hayashi J
    J Infect Chemother; 2008 Oct; 14(5):377-82. PubMed ID: 18936893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human parvovirus B19 in patients with aplastic anemia.
    Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
    Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Parvovirus B19 infection after renal transplantation].
    Rerolle JP; Helal I; Morelon E
    Nephrologie; 2003; 24(6):309-15. PubMed ID: 14584298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence.
    Kerr JR
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):335-9. PubMed ID: 16316396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slow clearance of human parvovirus B19 viremia following acute infection.
    Lindblom A; Isa A; Norbeck O; Wolf S; Johansson B; Broliden K; Tolfvenstam T
    Clin Infect Dis; 2005 Oct; 41(8):1201-3. PubMed ID: 16163641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome.
    Ware AJ; Moore T
    Clin Infect Dis; 2001 Apr; 32(7):E122-3. PubMed ID: 11264051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
    Hartmann JT; Meisinger I; Kröber SM; Weisel K; Klingel K; Kanz L
    Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient.
    Bilge I; Sadikoğlu B; Emre S; Sirin A; Aydin K; Tatli B
    Pediatr Nephrol; 2005 Apr; 20(4):529-33. PubMed ID: 15747163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura.
    Tavil B; Unal S; Aytaç-Elmas S; Yetgin S
    Turk J Pediatr; 2008; 50(1):74-7. PubMed ID: 18365597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parvovirus B19 infection mimicking juvenile myelomonocytic leukemia.
    Ozdemir N; Akı H; Hakyemez HT; Cokuğraş FÇ; Apak H
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e379-80. PubMed ID: 20599409
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.
    Plentz A; Hahn J; Holler E; Jilg W; Modrow S
    J Clin Virol; 2004 Sep; 31(1):16-9. PubMed ID: 15288608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W; Halim MA; Al-Nakib W
    Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.
    Koduri PR; Kumapley R; Valladares J; Teter C
    Am J Hematol; 1999 May; 61(1):16-20. PubMed ID: 10331506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
    Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
    Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation.
    Blaeser F; Kelly M; Siegrist K; Storch GA; Buller RS; Whitlock J; Truong N; Chatila TA
    Clin Immunol; 2005 Dec; 117(3):231-7. PubMed ID: 16169277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parvovirus B19-associated catastrophic endothelialitis with a Degos-like presentation.
    Dyrsen ME; Iwenofu OH; Nuovo G; Magro CM
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():20-5. PubMed ID: 18537856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection.
    Nyman M; Skjöldebrand-Sparre L; Broliden K
    J Perinat Med; 2005; 33(2):176-8. PubMed ID: 15843271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
    Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
    J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia.
    Mouthon L; Michel M; Gandré C; Montagnier-Petrissans C; Chevreul K
    Clin Infect Dis; 2015 Feb; 60(3):488. PubMed ID: 25336624
    [No Abstract]   [Full Text] [Related]  

  • 60. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
    Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
    J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.